Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

52.25 -1.14 (-2.14%)
Streaming Delayed Price Updated: 2:39 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,366,685
Open 54.31
Bid (Size) 52.22 (100)
Ask (Size) 52.28 (100)
Prev. Close 53.39
Today's Range 51.44 - 55.09
52wk Range 22.28 - 59.55
Shares Outstanding 394,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Healthcare Stocks We’re Skeptical Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the... 
Via MarketMinute

Performance

YTD
+69.3%
+69.3%
1 Month
+24.4%
+24.4%
3 Month
+76.3%
+76.3%
6 Month
+105.8%
+105.8%
1 Year
+49.2%
+49.2%

More News

Read More
Which S&P500 stocks are moving on Monday? ↗
Via Chartmill
News headline image
3 Unprofitable Stocks That Concern Us
Via StockStory
News headline image
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology
Via Finterra
Topics Initial Public Offering Intellectual Property
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement
Via MarketMinute
Topics Intellectual Property Lawsuit
News headline image
Moderna’s Renaissance: Why MRNA Surged 16% as the mRNA Platform Enters the Oncology Era
Via Finterra
Topics Intellectual Property
Tech Chips Lead Wall Street Rebound as Broadcom Crushes Estimates ↗
Via Chartmill
News headline image
Why Moderna (MRNA) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Moderna-Arbutus-Genevant Patent Settlement: Wall Street Says Not Best-Case Scenario But Removes Overhang For MRNA Stock ↗
Via Stocktwits
Topics Intellectual Property
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
2 High-Flying Stocks With More Upside to Buy and Hold ↗
Via The Motley Fool
Topics Artificial Intelligence Supply Chain
Get insights into the top movers in the S&P500 index of Wednesday's pre-market session. ↗
Via Chartmill
News headline image
MSTR, CRWD, MRNA, GTLB On Traders' Radar Today — Dow Futures Edge Higher As Investors Look Past Middle East Conflict ↗
Via Stocktwits
Topics ETFs Government Intellectual Property
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
MRNA Shares Rally After Hours On Inking Settlement Deal Over Vaccine Patent Row ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Moderna Resolves Global Patent Litigation with Arbutus/Genevant
Via ACCESS Newswire
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Moderna Stock (MRNA): Is It a Buy Now? 7 Questions After the Crash ↗
Via InvestorPlace
News headline image
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
Via Finterra
Topics Economy

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 52.25
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 03/13/26 02:39 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 20.59B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.